Rob Aboud
General Counsel at Affinia Therapeutics, Inc.
Rob Aboud active positions
| Companies | Position | Start | End |
|---|---|---|---|
Affinia Therapeutics, Inc.
 Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | General Counsel | 2019-07-31 | - |
Career history of Rob Aboud
Former positions of Rob Aboud
| Companies | Position | Start | End |
|---|---|---|---|
Faber Daeufer Itrato & Cabot PC
 Faber Daeufer Itrato & Cabot PC Miscellaneous Commercial ServicesCommercial Services Faber Daeufer Itrato & Cabot PC is an American company that provides legal services. | Corporate Officer/Principal | 2013-10-31 | 2019-07-31 |
Training of Rob Aboud
| Albright College | Undergraduate Degree |
| Rutgers State University of New Jersey | Graduate Degree |
| Temple University (Pennsylvania) | Graduate Degree |
Statistics
International
| United States | 5 |
| France | 2 |
Operational
| Graduate Degree | 2 |
| General Counsel | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Consumer Services | 4 |
| Commercial Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Faber Daeufer Itrato & Cabot PC
Faber Daeufer Itrato & Cabot PC Miscellaneous Commercial ServicesCommercial Services Faber Daeufer Itrato & Cabot PC is an American company that provides legal services. | Commercial Services |
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Rob Aboud
- Experience
